Enhanced epithelial to mesenchymal transition and chemoresistance in advanced Retinoblastoma tumors is driven by miR-181a
Vishnu Suresh Babu(Johns Hopkins University), Arkasubhra Ghosh(Narayana Nethralaya)
Cited by 2
Related Papers
Lack of Retinoblastoma Protein Shifts Tumor Metabolism from Glycolysis to OXPHOS and Allows the Use of Alternate Fuels
|Cells|2022|18
Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a
|Cancers|2022|14
Selective Induction of Intrinsic Apoptosis in Retinoblastoma Cells by Novel Cationic Antimicrobial Dodecapeptides
|Pharmaceutics|2022|7
AKT1-phosphorylated TERT assembles a FOXO3-MYC transcriptional complex that drives ERphagy and proteostasis in post-mitotic RPE
|bioRxiv (Cold Spring Harbor Laboratory)|2025|1
Attenuated adenosine mediated immune-dampening increases natural killer cell activity in early age-related macular degeneration
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0